Abstract
Multiple clinically applicable methods have been used to induce dendritic cells (DCs) to express whole cell tumor antigens, including pulsing DCs with tumor lysate, and mixing DCs with apoptotic or live tumor cells. Herein we demonstrate, using two different tumor systems, that these methods are equipotent inducers of systemic antitumor immunity. Furthermore, tumor lysate pulsed DC vaccines generate more potent antitumor immunity than immunization with irradiated tumor cells plus the classic adjuvant, Corynebacterium parvum.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Antigens, Neoplasm / administration & dosage*
-
Antigens, Neoplasm / radiation effects
-
Cancer Vaccines / administration & dosage*
-
Cancer Vaccines / radiation effects
-
Dendritic Cells / immunology*
-
Female
-
Mammary Neoplasms, Experimental / immunology
-
Mammary Neoplasms, Experimental / therapy
-
Mice
-
Mice, Inbred BALB C
-
Mice, Inbred C57BL
-
Propionibacterium acnes / immunology
-
Sarcoma, Experimental / immunology
-
Sarcoma, Experimental / therapy
Substances
-
Antigens, Neoplasm
-
Cancer Vaccines